Read more

Reslizumab: First Global Approval.

Related ArticlesReslizumab: First Global Approval.
Drugs. 2016 Apr 28;
Authors: Markham A
Abstract
Reslizumab (Cinqair(®)) is a humanised monoclonal interleukin-5 (IL-5) antibody developed by Teva that has…